Centric Compounding Issues Nationwide Recall of Glutathione, Myer's Cocktail, and Tri-Immune Boost Over Elevated Endotoxin Levels

What this means for your practice

Medspas, wellness clinics, telehealth brands, and any prescriber who orders or administers IV nutrient infusions or injectables from compounding pharmacies must treat this recall as an immediate operational priority. If your practice has dispensed or administered any of the six recalled lots of Glutathione, Myer's Cocktail, or Tri-Immune Boost from Centric Compounding, you must stop use immediately, quarantine remaining inventory, and notify affected patients. You should also review your compounding vendor due-diligence process: this recall underscores that compounded injectables carry sterility and endotoxin risks that require active pharmacovigilance — not just a standing purchase order. Document all recall-related actions in patient records, report any adverse events via FDA MedWatch, and confirm with your compounding pharmacy partners that their API sourcing and endotoxin testing protocols meet USP <85> and USP <797> standards. Failure to act promptly on a known recall creates significant liability exposure and potential state board scrutiny.

Centric Compounding Recalls Injectable Wellness Products Over Elevated Endotoxin

Company announcement: dated September 9, 2026 (FDA lists the announcement date as September 11, 2026) Posted by FDA: September 13, 2026 Products affected: Compounded Glutathione 200 mg/mL, Myer's Cocktail and Tri-Immune Boost (30 mL multidose vials)

What Happened

Centric Compounding LLC of Houston, Texas, is voluntarily recalling six lots of injectable compounded products: Glutathione 200 mg/mL, Myer's Cocktail and Tri-Immune Boost. The company traced the problem to the glutathione active pharmaceutical ingredient (API) used to compound all three products, which had elevated endotoxin levels.

The recall was initiated by the company, and FDA posted the company's announcement. As of FDA's enforcement report dated October 14, 2026, FDA's entry for the Tri-Immune Boost lot was listed as "Not Yet Classified," with the reason given as out-of-specification bacterial endotoxin results. FDA, not the company, assigns the recall class.

Why Endotoxins in Injectables Are Dangerous

Endotoxins are components of the cell walls of certain bacteria. In an injectable product, elevated levels can trigger serious systemic reactions. The company's announcement says injectable products with elevated endotoxin levels could cause:

• Fever
• Hypotension (low blood pressure)
• Inflammatory reactions
• Anaphylactic shock
• Death

At the time of the announcement, Centric Compounding had received 9 reports of adverse events: fever, chills, chest pain, nausea or vomiting, headache, and malaise.

Affected Lots: Full List

Note: Every one of these beyond-use dates has now passed, but vials may still be in clinic storage or in patients' homes. A vial past its beyond-use date should not be used in any case, and these lots should be discarded as the recall directs.

How the Products Were Distributed

Centric Compounding distributed these products nationwide: - Directly to patients through home delivery - To prescribers

The company says it is notifying its distributors and customers by email and arranging replacement of all recalled products. Because some vials went straight to patients' homes, the recall reaches beyond clinic inventory.

Required Actions for Consumers and Prescribers

1. Stop using any of the recalled lots. 2. Discard the affected vials. 3. Contact Centric Compounding about replacement: - Phone: 833-777-6664 - Email: info@centriccompounding.com - Hours: Monday to Friday, 9 a.m. to 5 p.m. CST 4. Contact a physician or healthcare provider about any problems that may be related to the product. 5. Report adverse events to FDA MedWatch: - Online: www.fda.gov/medwatch/report.htm - By mail or fax: download the form at www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request one, then mail it to the address on the form or fax it to 1-800-FDA-0178.

What This Means for Practices That Order or Administer These Products

This recall matters to any practice that orders, prescribes or administers compounded injectable wellness products, in particular IV nutrient therapy clinics, medspas offering injectables, and telehealth programs whose prescriptions are filled with compounded injectables shipped to patients.

Immediate steps:

• Audit your inventory. Check all Centric Compounding injectable stock against the six lot numbers above.
• Identify and contact affected patients. If any recalled lot was administered in your clinic or shipped to patients under your prescriptions, contact those patients, ask about symptoms, and document the outreach.
• Quarantine and do not administer any recalled product, including partially used vials.
• Document everything. Record when you learned of the recall, your inventory review, patient outreach and disposal.
• Report adverse events. If patients report symptoms that may be related, file a MedWatch report.
• Review your compounding pharmacy relationships. Ask your pharmacies how they qualify their API suppliers and what endotoxin testing they perform on sterile preparations, and confirm the pharmacy is licensed in its own state and in the states where your patients are.

Longer term: Sterile injectables carry more risk than other compounded products, because a contaminated ingredient goes straight into the bloodstream. Treat due diligence on compounding pharmacy partners as an ongoing responsibility rather than a one-time credentialing step: keep a current list of which pharmacy supplies which product, so that the next recall notice can be matched to your patients in hours, not days.

Key Facts

Frequently Asked Questions

Which specific products and lots are being recalled?

Six lots across three products: Glutathione 200 mg/mL (lots 062326:B, 070826:A, 072726:D), Myer's Cocktail (lots 070226:D, 072126:A) and Tri-Immune Boost (lot 071626:B), all in 30 mL multidose vials made by Centric Compounding LLC.

What are the health risks of these recalled products?

The company says injectable products with elevated endotoxin levels could cause fever, low blood pressure, inflammatory reactions, anaphylactic shock and death. It had received 9 reports of adverse events, including fever, chills, chest pain, nausea or vomiting, headache and malaise.

What should a clinic or medspa do if it has these products in stock?

Stop using and discard any affected vials. Contact Centric Compounding at 833-777-6664 or info@centriccompounding.com about replacement, and document every step.

What should we do if a patient reports symptoms after receiving one of these products?

Direct the patient to contact their physician or healthcare provider. Report the adverse reaction to FDA's MedWatch program online at www.fda.gov/medwatch/report.htm, or by mail or fax using the form (call 1-800-332-1088 to request one; fax 1-800-FDA-0178).

Were these products distributed only to clinics, or also directly to patients?

Both. Centric Compounding distributed the recalled products nationwide to patients by home delivery and to prescribers, so practices that prescribed these products for home use may need to reach their patients directly.

Has FDA classified this recall?

Not as of FDA's enforcement report dated October 14, 2026, which listed the Tri-Immune Boost lot as "Not Yet Classified." The company initiated the recall; FDA assigns the class once it reviews the health hazard.

Source: FDA: Centric Compounding Issues Nationwide Recall of Glutathione, Myer's Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels · September 13, 2026. Classification status: openFDA drug enforcement data (api.fda.gov/drug/enforcement.json), report date October 14, 2026.